Risk Factors and Treatment for Hepatocellular Carcinoma.
作者信息
Gish Robert G
机构信息
Medical Director, Liver Transplant Program California Pacific Medical Center.
出版信息
Gastroenterol Hepatol (N Y). 2006 Jul;2(7):477-478.
Abstract
摘要
相似文献
1
Risk Factors and Treatment for Hepatocellular Carcinoma.肝细胞癌的危险因素与治疗
Gastroenterol Hepatol (N Y). 2006 Jul;2(7):477-478.
2
Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.2型糖尿病与肝细胞癌：危险因素与发病机制
Curr Diab Rep. 2017 Apr;17(4):20. doi: 10.1007/s11892-017-0851-x.
3
Independent risk factors for hepatocellular carcinoma in French drinkers.法国饮酒者患肝细胞癌的独立危险因素。
Hepatology. 1991 May;13(5):896-901.
4
Risk factors for hepatocellular carcinoma: a case-control study in Belgrade (Serbia).肝细胞癌的危险因素：在贝尔格莱德（塞尔维亚）进行的一项病例对照研究。
Tumori. 2010 Nov-Dec;96(6):911-7.
5
Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.日本人群肝细胞癌的危险因素：一项巢式病例对照研究。
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):846-54. doi: 10.1158/1055-9965.EPI-07-2806.
6
Hepatocellular carcinoma.肝细胞癌
Curr Opin Gastroenterol. 2006 May;22(3):248-53. doi: 10.1097/01.mog.0000218961.86182.8c.
7
Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.α干扰素治疗可能预防丙型肝炎病毒相关肝硬化中的肝细胞癌。
J Hepatol. 1996 Feb;24(2):141-7. doi: 10.1016/s0168-8278(96)80022-5.
8
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.接受 DAA 治疗的晚期丙型肝炎患者新诊断的肝细胞癌：一项前瞻性人群研究。
J Hepatol. 2018 Aug;69(2):345-352. doi: 10.1016/j.jhep.2018.03.009. Epub 2018 Mar 16.
9
10
Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study.希腊克里特岛肝硬化和肝细胞癌发病率及危险因素的长期变化：一项为期25年的研究。
Ann Gastroenterol. 2017;30(3):357-363. doi: 10.20524/aog.2017.0135. Epub 2017 Mar 23.
引用本文的文献
1
Cirrhosis and Chronic Viral Hepatitis as Risk Factors for Hepatocellular Carcinoma: Romanian Single-clinic Experience.肝硬化和慢性病毒性肝炎作为肝细胞癌的危险因素：罗马尼亚单中心经验
Maedica (Bucur). 2010 Dec;5(4):265-70.
本文引用的文献
1
The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (</=3cm) in patients with cirrhosis.肝硬化患者小肝细胞癌（<=3cm）的超声造影诊断作用。
Hepatol Res. 2006 Aug;35(4):281-8. doi: 10.1016/j.hepres.2006.04.013. Epub 2006 Jun 19.
2
New frontiers in biomarkers for hepatocellular carcinoma.肝细胞癌生物标志物的新前沿。
Dig Liver Dis. 2006 Nov;38(11):854-9. doi: 10.1016/j.dld.2006.05.007. Epub 2006 Jun 19.
3
Recurrence of diseases following orthotopic liver transplantation.原位肝移植后疾病的复发
Am J Gastroenterol. 2006 Jun;101(6):1370-8. doi: 10.1111/j.1572-0241.2006.00586.x.
4
Hepatocellular carcinoma: overcoming challenges in disease management.肝细胞癌：克服疾病管理中的挑战
Clin Gastroenterol Hepatol. 2006 Mar;4(3):252-61. doi: 10.1016/j.cgh.2006.01.001.
5
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.
6
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.美国丙型肝炎相关肝细胞癌：种族状况的影响
Am J Gastroenterol. 2003 Sep;98(9):2060-3. doi: 10.1111/j.1572-0241.2003.t01-1-07641.x.
Zotero 插件